Chair Capital: Valuation Anchor & Principal Investor

Patternox has entered into an engagement with Chair Capital, a private investment firm acting as Valuation Anchor and Investor. Chair Capital's commitment establishes a defined institutional valuation reference and milestone framework against which interim and co-investment participation can be priced, de-risking participation for incoming investors. As part of its investment architecture, Chair Capital has confirmed its intention to retire loan notes and equity instruments raised during the interim financing process at the point of its principal investment entry, subject to achieving a target IRR, providing early-stage investors with a clear and defined exit pathway. This structure removes the open-ended exit uncertainty that typically increases the cost of early-stage capital, and positions Patternox current fundraise as a time-defined opportunity to invest ahead of an institutional anchor commitment.

​

Last years

✔ The methodology study was approved as exempt by the IRB.

✔ We were awarded the first prize for innovation in a TV contest based on the Shark Tank show.

✔ Working with UNIVO IRB, UNIVO is compliant with regulations that relate to the protection of research participants within the Code of Federal Regulations (CFR).​

✔ The  Israel Innovation Authority (IIA) chose us to participate in the Singapore-Israeli delegation.​​​

✔ Won a contest by Vision-Elements (AI).

✔ Clinical trial with over 500 lesions, and more than 15,000 measurements.

✔ Regulatory strategy By Duet Medical and GSAP.

✔ Patent, at a national stage and after IDS (Information Disclosure Statement) in November 2024. 

✔ New PatScope Scanner (MVP, trl6).

✔ Business plan. Business model.

✔ Conference presentations.

✔ Proposal to Space Agency to investigate astronaut's skin degradation under microgravity conditions.

​